Last update 08 May 2025

Tenofovir alafenamide/Emtricitabine/Dolutegravir

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
KOCITAF
Target-
Action-
Mechanism-
Therapeutic Areas
Immune System DiseasesInfectious DiseasesUrogenital Diseases
Active Indication
HIV Infections
Inactive Indication-
Originator Organization
Mylan NVMylan NV
Active Organization
Lupin Pharmaceuticals, Inc.Lupin Pharmaceuticals, Inc.Laurus Labs Ltd.Laurus Labs Ltd.Hetero Labs Ltd.
Inactive Organization
Mylan NVMylan NV
License Organization-
Drug Highest PhaseNDA/BLA
First Approval Date-
RegulationThe United States President's Emergency Plan for AIDS Relief (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC20H19F2N3O5
InChIKeyRHWKPHLQXYSBKR-BMIGLBTASA-N
CAS Registry1051375-16-6
View All Structures (3)

Related

100 Clinical Results associated with Tenofovir alafenamide/Emtricitabine/Dolutegravir
Login to view more data
100 Translational Medicine associated with Tenofovir alafenamide/Emtricitabine/Dolutegravir
Login to view more data
100 Patents (Medical) associated with Tenofovir alafenamide/Emtricitabine/Dolutegravir
Login to view more data
100 Deals associated with Tenofovir alafenamide/Emtricitabine/Dolutegravir
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HIV InfectionsNDA/BLA
United States
Lupin Pharmaceuticals, Inc.Lupin Pharmaceuticals, Inc.
-
HIV InfectionsNDA/BLA
United States
Hetero Labs Ltd.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
VISEND (IAS2022)
Not Applicable
HIV Infections
837
rzeqxuuokk(gdziopuqof) = 2 individuals were discontinued due to bone related events rgpimrghgk (necpdyaqbq )
View more
-
01 Jan 2022
VISEND (IAS2022)
Not Applicable
HIV Infections
-
uwszhrrrkb(vbvilhoann) = eflobshazn edsioxjzoy (qgzfgjfzce )
View more
-
01 Jan 2022
uwszhrrrkb(vbvilhoann) = mtzmhoowzq edsioxjzoy (qgzfgjfzce )
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free